NOVAMED A/S: Financial statements 2023
CVR: 34589569
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NOVAMED A/S (CVR 34589569) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 4,638,145 and a net result of DKK 600,217 compared with DKK 3,415,107 the year before. That is a decrease of 42.2% compared with the year before. Equity in the 2023 report amounted to DKK 5,471,378. The solvency ratio was 53.3%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 4,638,145
- Profit/Loss
- DKK 600,217
- Equity
- DKK 5,471,378
- Total Assets
- DKK 10,264,514
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 4.6M | 600K | 5.5M | 3 |
| 2022 | - | 8M | 3.4M | 8.4M | 3 |
| 2021 | - | 5.2M | 1.8M | 5M | 3 |
| 2020 | - | 7.7M | 3.2M | 7.2M | 3 |
| 2019 | - | 6.1M | 2.2M | 5.9M | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
NOVAMED A/S has published its annual report for 2022. Gross profit came to DKK 8,025,068, and the net result was DKK 3,415,107.
About NOVAMED A/S
NOVAMED A/S is a Danish company of the type Aktieselskab based in Roskilde, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named HOMECLINIC ApS and NOVAMED ApS. The management consists of Ulrich Rothaus Andersen. The board consists of Anne Stendys, Jacob Rothaus Stendys and Ulrich Rothaus Andersen. The company is owned by Rothaus Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 6,590,260 and a net result of DKK 2,053,316 compared with DKK 1,732,738 the year before. Equity in the 2025 report amounted to DKK 5,257,432.